"Under the Radar" uncovers little-known companies worthy of investors' consideration. Check in at 5 every morning to find out about stocks that tend to beat their bigger brethren.
BOSTON (TheStreet) -- Modernity is synonymous with vanity.
The status-anxious consumer will shell out for aesthetic upgrades, and investors can capitalize on the trend. Nu Skin Enterprises (NUS) is a small-cap skin-care specialist that offers international exposure and consistent growth. Its focus on anti-aging and weight-loss products is both savvy and lucrative. But with a $1.7 billion market value, Nu Skin is a personal-products stock off the beaten trail.
The company's third-quarter net income surged 53% to $26 million, and earnings per share rocketed 54% to 40 cents. Revenue increased 8% to $334 million. Nu Skin's operating margin widened from 10% to 12%, helped by lower selling and administrative expenses. A $12 million restructuring charge hurt the bottom line.Nu Skin derives most of its revenue from North Asia, which includes Japan and South Korea. During the third quarter, revenue in that region declined 1% to $438 million. Greater China revenue also decreased, falling 2% to $155 million. But revenue in the Americas ascended 10% to $181 million, and Europe revenue rose 11% to $93 million. The South Asia/Pacific region registered a 4% jump to $85 million. During the past three years, revenue grew 4% annually, on average, as earnings per share advanced 37% a year. Return on equity, a key measure of profitability, rose from 18% to 25% in the third quarter, beating the 3% average of S&P 500 Index member companies, but trailing the personal-products industry average of 34%. Nu Skin has paid dividends since 2001 and currently offers a 1.7% yield, less than the 2.8% average of S&P 500 components.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV